Abstract
This chapter focuses on the classification, presentation, diagnosis, and treatment of common and less common neuromuscular disorders such as myopathies, neuropathies, and neuromuscular junction disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amato AA, Greenberg SA. Inflammatory myopathies. Continuum (Minneap Minn). 2013;19(6, Muscle Disease):1615–33.
Bird TD. In: Pagon RA, Adam MP, Bird TD, editors. Hereditary neuropathy with liability to pressur palsies. GeneReviewsâ„¢ [Internet]. Seattle: University of Washington; 2014, 1993.
Eagle M, Baudouin SV, Chandler C, et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord. 2002;12(10):926–9.
Fenichel GM, Florence JM, Pestonk A, et al. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology. 1991;41(12):1874–7.
Flanigan KM. Duchenne and Becker muscular dystrophies. Neurol Clin. 2014;32(3):671–88.
Gilchrist JM, Massey JM, Sanders DB. Single fiber EMG and repetitive stimulation of the same muscle in myasthenia gravis. Muscle Nerve. 1994;17(2):171–5.
Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023–36.
Harel T, Lupski JR. Charcot-Marie-Tooth disease and pathways to molecular based therapies. Clin Genet. 2014 Nov;86(5):422–31.
Hughes RAC. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Lancet. 1997;349(9047):225–30.
Katzberg HD, Kassrdijan CD. Toxic and endocrine myopathies. Continuum (Minneap Minn). 2016;22:1815–28.
Loavenbruck AJ, Singer W, Mauermann M, Sandroni P, Dyck PJ B, Gertz M, et al. Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox? Ann Neurol. 2016;80(3):401–11.
Mammen AL. Autoimmune myopathies. Continuum. 2016;22:1852–70.
Mendell JR, Moxley RT, Griggs RC, et al. Randomized, double-blind six-month trial of prednisone in Duchenne’s muscular dystrophy. N Engl J Med. 1989;320(24):1592–7.
Mitsumoto H, Brooks BR, Silani V. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved? Lancet Neurol. 2014;13(11):1127–38.
Nguyen TP, Chaudhry V. Multifocal motor neuropathy. Neurol India. 2011;59(5):700–6.
O’Malley R, Rao G, Stein P, Bandmann O. Porphyria: often discussed but too often missed. Pract Neurol. 2018;0:1–7.
Pickrell WO, Hirst C, Brunt H, Pearson OR. Peripheral neuropathy- lead astray? Lancet. 2013;381:1156.
Schaublin GA, Michet CJ, Dyck PJ, Burns TM. An update on the classification and treatment of vasculitic neuropathy. Lancet Neurol. 2005;4(12):853–65.
Statland JM, Tawil R. Facioscapulohumeral muscular dystrophy. Continuum. 2016;22:1916–31.
Thornton CA. Myotonic dystrophy. Neurol Clin. 2014;32(3):705–19.
Tiryaki E, Horak HA. ALS and other motor neuron diseases. Continuum (Minneap Minn). 2014;20(5, Peripheral Nervous System Disorders):1185–207.
Titulaer MJ, Lang B, Verschuuren JJ. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011;10(12):1098–107.
Viollet L, Thrush PT, Flanigan KM, et al. Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy. Am J Cardiol. 2012;110(1):98–102.
Waldfogel JM. Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: a systematic review. Neurology. 2017;88(20):16.
Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388(10045):717–27.
Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012;366(24):2294–304.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kung, D., Nguyen, T., Das, R. (2019). Neuromuscular Disorders. In: Absolute Case-Based Neurology Review. Springer, Cham. https://doi.org/10.1007/978-3-030-11132-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-11132-8_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11131-1
Online ISBN: 978-3-030-11132-8
eBook Packages: MedicineMedicine (R0)